Annual Drug Patent Expirations for OXLUMO
Oxlumo is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twelve patents protecting this drug.
This drug has one hundred and twenty-seven patent family members in thirty-seven countries.
The generic ingredient in OXLUMO is lumasiran sodium. Additional details are available on the lumasiran sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com